129 related articles for article (PubMed ID: 20169706)
1. The treatment of disseminated prostate cancer with estramustine.
Rosenthal MA; Raghavan D; Stuart-Harris R; Ackland S; Grygiel J
Aust N Z J Surg; 1992 Nov; 62(11):871-3. PubMed ID: 20169706
[TBL] [Abstract][Full Text] [Related]
2. Phase II trial of neoadjuvant estramustine and etoposide plus radical prostatectomy for locally advanced prostate cancer.
Clark PE; Peereboom DM; Dreicer R; Levin HS; Clark SB; Klein EA
Urology; 2001 Feb; 57(2):281-5. PubMed ID: 11182337
[TBL] [Abstract][Full Text] [Related]
3. Combination of docetaxel, estramustine phosphate, and zoledronic acid in androgen-independent metastatic prostate cancer: efficacy, safety, and clinical benefit assessment.
Efstathiou E; Bozas G; Kostakopoulos A; Kastritis E; Deliveliotis C; Antoniou N; Skarlos D; Papadimitriou C; Dimopoulos MA; Bamias A
Urology; 2005 Jan; 65(1):126-30. PubMed ID: 15667877
[TBL] [Abstract][Full Text] [Related]
4. Cellular changes in prostatic carcinoma after treatment with orchidectomy, estramustine phosphate and medroxyprogesterone acetate.
Tomic R; Angström T; Ljungberg B
Scand J Urol Nephrol; 1997 Jun; 31(3):255-8. PubMed ID: 9249888
[TBL] [Abstract][Full Text] [Related]
5. The flare in alkaline phosphatase activity post-orchidectomy predicts which patient may benefit from early chemotherapy in metastatic prostate cancer.
Pelger RC; Lycklama A Nijeholt GA; Zwinderman AH; Hamdy NA
Prostate; 2002 Feb; 50(2):119-24. PubMed ID: 11816020
[TBL] [Abstract][Full Text] [Related]
6. Combination of LHRH analog with somatostatin analog and dexamethasone versus chemotherapy in hormone-refractory prostate cancer: a randomized phase II study.
Dimopoulos MA; Kiamouris C; Gika D; Deliveliotis C; Giannopoulos A; Zervas A; Alamanis C; Constantinidis C; Koutsilieris M
Urology; 2004 Jan; 63(1):120-5. PubMed ID: 14751362
[TBL] [Abstract][Full Text] [Related]
7. Estramustine phosphate versus placebo as second line treatment after orchiectomy in patients with metastatic prostate cancer: DAPROCA study 9002. Danish Prostatic Cancer Group.
Iversen P; Rasmussen F; Asmussen C; Christensen IJ; Eickhoff J; Klarskov P; Larsen E; Mogensen P; Mommsen S; Rosenkilde P
J Urol; 1997 Mar; 157(3):929-34. PubMed ID: 9072602
[TBL] [Abstract][Full Text] [Related]
8. Oral estramustine and cyclophosphamide in patients with metastatic hormone refractory prostate carcinoma: a phase II study.
Bracarda S; Tonato M; Rosi P; De Angelis V; Mearini E; Cesaroni S; Fornetti P; Porena M
Cancer; 2000 Mar; 88(6):1438-44. PubMed ID: 10717628
[TBL] [Abstract][Full Text] [Related]
9. [Effect of estramustine phosphate on hormone refractory prostate cancer].
Tanaka M; Shiomi K; Hamano S; Suzuki N; Igarashi T; Murakami S; Shimazaki J
Hinyokika Kiyo; 1997 Mar; 43(3):245-50. PubMed ID: 9127765
[TBL] [Abstract][Full Text] [Related]
10. Effect of zoledronic acid on metastatic hormone-refractory prostate cancer resistant to taxane, estramustine, carboplatin, and dexamethasone.
Kikuno N; Urakami S; Nakamura S; Shiina H; Igawa M
Int J Urol; 2007 Jan; 14(1):82-4. PubMed ID: 17199867
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant docetaxel and estramustine chemotherapy in high-risk/locallyadvanced prostate cancer.
Hussain M; Smith DC; El-Rayes BF; Du W; Vaishampayan U; Fontana J; Sakr W; Wood D
Urology; 2003 Apr; 61(4):774-80. PubMed ID: 12670564
[TBL] [Abstract][Full Text] [Related]
12. Effect of concomitant administration of clodronate and estramustine phosphate on their bioavailability in patients with metastasized prostate cancer.
Kylmälä T; Castrén-Kortekangas P; Seppänen J; Ylitalo P; Tammela TL
Pharmacol Toxicol; 1996 Sep; 79(3):157-60. PubMed ID: 8884875
[TBL] [Abstract][Full Text] [Related]
13. [The place of estramustine in the treatment of prostate cancer].
Pintér O; Tóth C; Szabó Z; Lipták J; Fél P; Papp G; Holman E; Hazay L; Streit B; Kisbenedek L; Fehér M; Kocsis I
Orv Hetil; 2005 Mar; 146(12):553-7. PubMed ID: 15853064
[TBL] [Abstract][Full Text] [Related]
14. Treatment of stage D hormone-resistant carcinoma of the prostate with estramustine phosphate.
Benson RC; Wear JB; Gill GM
J Urol; 1979 Apr; 121(4):452-4. PubMed ID: 439216
[TBL] [Abstract][Full Text] [Related]
15. The use of estramustine phosphate in the modern management of advanced prostate cancer.
Ravery V; Fizazi K; Oudard S; Drouet L; Eymard JC; Culine S; Gravis G; Hennequin C; Zerbib M
BJU Int; 2011 Dec; 108(11):1782-6. PubMed ID: 21756277
[TBL] [Abstract][Full Text] [Related]
16. Combination chemotherapy with estramustine phosphate, ifosfamide and cisplatin for hormone-refractory prostate cancer.
Kaku H; Saika T; Tsushima T; Nagai A; Yokoyama T; Abarzua F; Ebara S; Manabe D; Nasu Y; Kumon H
Acta Med Okayama; 2006 Feb; 60(1):43-9. PubMed ID: 16508688
[TBL] [Abstract][Full Text] [Related]
17. Bisphosphonate therapy for hormone refractory prostate cancer with bone metastasis.
Asahi H; Mizokami A; Maeda Y; Komatsu K; Koshida K; Namiki M
J Urol; 2003 Jan; 169(1):281-2. PubMed ID: 12478161
[No Abstract] [Full Text] [Related]
18. Estramustine phosphate combined with orchidectomy as first-line therapy in patients with prostate carcinoma. Effect of age on survival.
Pelger RC; Lycklama A Nijeholt Ga; Zwinderman AH; Hamdy NA
Cancer; 2002 May; 94(10):2596-601. PubMed ID: 12173326
[TBL] [Abstract][Full Text] [Related]
19. Hemolytic-uremic syndrome during therapy with estramustine phosphate for advanced prostatic cancer.
Tassinari D; Sartori S; Panzini I; Ravaioli A; Iorio D
Oncology; 1999; 56(2):112-3. PubMed ID: 9949296
[TBL] [Abstract][Full Text] [Related]
20. Combined hormono/chemotherapy as primary treatment for metastatic prostate cancer: a randomized, multicenter study of orchiectomy alone versus orchiectomy plus estramustine phosphate. The Dutch Estracyt Study Group.
Janknegt RA; Boon TA; van de Beek C; Grob P
Urology; 1997 Mar; 49(3):411-20. PubMed ID: 9123707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
